Onchocerciasis Treatments
Find Onchocerciasis Treatments
Brand Name
Moxidectin
View Brand InformationFDA approval date: December 02, 2019
Form: Tablet
What is Moxidectin?
Moxidectin Tablets are indicated for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older. Limitations of Use: Moxidectin Tablets do not kill adult O. volvulus. Follow-up evaluation is advised. The safety and efficacy of repeat administration of Moxidectin Tablets in patients with O. volvulus has not been studied. Moxidectin is an anthelmintic indicated for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older. Limitations of Use: Moxidectin Tablets do not kill adult O. volvulus parasites. Follow-up is advised. The safety and efficacy of repeat administration of Moxidectin Tablets in patients with O. volvulus has not been studied.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases: A Cluster-randomised Trial
Summary: This clinical trial compares two treatments - ivermectin and moxidectin - to learn which is better at reducing the proportion of people with onchocerciasis (river blindness) when given through mass drug administration (MDA) in Angola. Both drugs are approved by the United States Food and Drug Administration (FDA) to treat this disease. The study also explores how these treatments affect other infe...